We've developed campaigns for more than 200 brands over the past decade. These range from blockbusters with target audiences over 100,000 HCPs to rare diseases with less than 300 targets. While we can't show them all, we've highlighted a few which will give you a good sampling of our work.
In patients diagnosed with HIV, ART therapy is the standard protocol. However, a common side effect of ART therapy is noninfectious diarrhea, which up to 27% of patients suffer over the course of 1 year of therapy. HIV patients are often hesitant to discuss diarrhea for several reasons: they are unaware it is a side effect of medication, their primary concern is decreased viral load and they are willing to accept the side effect, or they are unaware there is a prescription medication available to help alleviate the diarrhea.
Utilizing a unique MOA and active ingredient, this launch product needed help highlighting the prevalence and impact on patients for infectious disease HCPs.